Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 18;18(2):353-364.
doi: 10.5114/aoms.2020.98909. eCollection 2022.

New findings in oligogenic inheritance of congenital hypogonadotropic hypogonadism

Affiliations

New findings in oligogenic inheritance of congenital hypogonadotropic hypogonadism

Agnieszka Gach et al. Arch Med Sci. .

Abstract

Introduction: Congenital hypogonadotropic hypogonadism results from a dysfunction of the hypothalamic-pituitary-gonadal axis, which is essential for the development and function of the reproductive system. It may be associated with anosmia, referred to as Kallmann syndrome, or a normal sense of smell. Numerous studies have proven that hypogonadotropic hypogonadism is not simply a monogenic Mendelian disease, but that more than one gene may be involved in its pathogenesis in a single patient. The oligogenic complex architecture underlying the disease is still largely unknown.

Material and methods: Targeted next-generation sequencing (NGS) was used to screen for DNA variants in a cohort of 47 patients with congenital hypogonadotropic hypogonadism. The NGS panel consists of over 50 well-known and candidate genes, associated with hypogonadotropic state.

Results: Here we report the identification of new oligogenic variants in SPRY4/SEMA3A, SRA1/SEMA7A, CHD7/SEMA7A, CCDC141/POLR3B/POLR3B, and PROKR2/SPRY4/NSMF. These genes are known to contribute to the phenotype of hypogonadotropic hypogonadism, yet our results point to potential new "partners" underlying digenic and trigenic patterns.

Conclusions: The finding supports the importance of oligogenic inheritance and demonstrates the complexity of genetic architecture in hypogonadotropic hypogonadism. It also underlines the necessity for developing fine-tuned guidelines to provide a tool for adequate and precise sequence variant classification in non-Mendelian conditions.

Keywords: Kallmann syndrome; hypothalamic-pituitary-gonadal axis; oligogenicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Targeted sequencing identifies oligogenic variants in CHH patients. A – Segregation of identified variants within families. Probands/affected individuals are identified by the arrow. Circles denote females; squares denote males. M: mutation; NT: not tested. B – Sequence chromatograms of affected patients. Family 1: SPRY4: c.722C>A and SEMA3A: c. 1303G>A; M2 chromatogram identifies both a rare variant and a common polymorphism rs7804122 (the dotted line arrow). Family 2: SEMA7A: c. 618_619delCC and CHD7: c. 2840G>A. Family 3: SEMA7A: c. 916G>A and SRA1: c. 377G>A. Family 4: CCDC141: c. 2299G>A and POLR3B: c. 1244T>C; 2570+1G>A. Family 5: PROKR2:c. 889G>T, SPRY4:c. 530A>G, and NSMF: c. 1261C>T. The site of mutation is identified by the arrow
Figure 2
Figure 2
Genes linked to oligogenic inheritance in the studied CHH cohort. A – List of genes with genomic coordinates for the GRCh38 reference assembly. B – Gene-gene interaction based on online tool https://genemania.org/. C – Chromosomal localisation of genes of interest based on https://www.ncbi.nlm.nih.gov/genome/tools/gdp

Similar articles

Cited by

References

    1. Bianco SDC, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009;5:569–76. - PMC - PubMed
    1. Bhagavath B, Podolsky RH, Ozata M, et al. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil Steril. 2006;85:706–13. - PubMed
    1. Wray S, Grant P, Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc Natl Acad Sci. 1989;86:8132–6. - PMC - PubMed
    1. Selcuk S, Bilgic BE, Kilicci C, et al. Comparison of ovarian responsiveness tests with outcome of assisted reproductive technology – a retrospective analysis. Arch Med Sci. 2018;14:851–9. - PMC - PubMed
    1. Tian LF, Tan J, Zou Y, et al. Mild starting dosage ovarian stimulation combined with a modified prolonged GnRH-a protocol improved IVF/ICSI outcomes in normal ovarian responders. Arch Med Sci. 2019;15:1294–300. - PMC - PubMed